Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2017

Giulino-Roth L, van Besien HJ, Dalton T, Totonchy JE, Rodina A, Taldone T, et al. Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma. Mol Cancer Ther. 2017;16(9):1779-1790.

Wolgast LR, Arslan AA, Wu X-, Beyda JN, Pengo V, Rand JH. Reduction of annexin A5 anticoagulant ratio identifies antiphospholipid antibody-positive patients with adverse clinical outcomes. J Thromb Haemost. 2017;15(7):1412-1421.

Moschini M, Soria F, Susani M, Korn S, Briganti A, Rouprêt M, et al. Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy. Bladder Cancer. 2017;3(3):161-169.

Pisapia DJ, Magge R, Ramakrishna R. Improved Pathologic Diagnosis-Forecasting the Future in Glioblastoma. Front Neurol. 2017;8:707.

Cao Z, Scandura JM, Inghirami GG, Shido K, Ding B-, Rafii S. Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells. Cancer Cell. 2017;31(1):110-126.

Rajappa P, Cobb WS, Vartanian E, Huang Y, Daly L, Hoffman C, et al. Malignant Astrocytic Tumor Progression Potentiated by JAK-mediated Recruitment of Myeloid Cells. Clin Cancer Res. 2017;23(12):3109-3119.

Whipple KM, Godfrey KJ, Solomon JP, Lin JH, Korn BS, Kikkawa DO. Glomuvenous Malformation: A Rare Periorbital Lesion of the Thermoregulatory Apparatus. Ophthalmic Plast Reconstr Surg. 2017;33(2):e36-e37.

Nguyen GH, Olson LC, Magro CM. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome. Ann Diagn Pathol. 2017;28:54-59.

Cheng E, D'Alfonso TM, Arafah M, Rolon RM, Ginter PS, Hoda SA. Subareolar Sclerosing Ductal Hyperplasia. Int J Surg Pathol. 2017;25(1):4-11.

Wang JY, Nuovo G, Kline M, Magro CM. Reexcision Perineural Invasion and Epithelial Sheath Neuroma Possibly on a Spectrum of Postinjury Reactive Hyperplasia Mediated by IL-6. Am J Dermatopathol. 2017;39(1):49-52.